Armistice Capital’s Silexion Therapeutics SLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$146K Buy
+21,875
New +$648K ﹤0.01% 322

Other funds holding SLXN

Armistice Capital's SLXN Position: Q3 2026 in Review

Armistice Capital opened a new position in Silexion Therapeutics (SLXN) in Q3 2026: 21,875 shares worth $146K. The stake represents ﹤0.01% of the portfolio and ranks #322 among its holdings.

10 funds tracked by Wall St. Rank hold SLXN as of Q3 2026.

  • Armistice Capital held 21,875 shares of Silexion Therapeutics worth $146K as of Q3 2026.
  • Silexion Therapeutics was a new Armistice Capital position in Q3 2026.
  • Silexion Therapeutics made up ﹤0.01% of Armistice Capital's portfolio in Q3 2026, its #322 holding.
  • 10 funds tracked by Wall St. Rank held Silexion Therapeutics as of Q3 2026.

Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.